Firyal S. Khan‐Dawood

article 1997

Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis

American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(97)70504-0

ObjectiveOur purpose was to determine and compare the efficacy and hormonal and metabolic effects of 1.25 mg with 2.5 mg of gestrinone given twice a week in the treatment of mild and moderate pelvic endometriosis.Study designA phase II, pro…

article 1988

Plasma and peritoneal fluid levels of CA 125 in women with endometriosis

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(88)90588-1

Determined by a sandwich, solid-phase radioimmunoassay with mouse monoclonal antibody, OC 125, plasma CA 125 levels were significantly elevated in stage III (mean +/- SEM = 32.7 +/- 5.2 U/ml, n = 17, p = less than 0.01) and stage IV endomet…

article 1987

Human corpus luteum: Presence of epidermal growth factor receptors and binding characteristics

·doi:10.1016/0002-9378(87)90362-0

Epidermal growth factor receptors are present in many reproductive tissues but have not been demonstrated in the human corpus luteum. To determine the presence of epidermal growth factor receptors and its binding characteristics, we carried…

article 1987

Protein, progesterone, and protease inhibitors in uterine and peritoneal fluids of women with endometriosis

Fertility and sterility ·doi:10.1016/s0015-0282(16)49994-2

This study was undertaken to determine whether women with endometriosis have altered protein, progesterone (P), and protease inhibitor concentrations in their uterine fluid and peritoneal fluid (PF) compared with controls at different phase…

article 1984

Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(84)90713-0

Peritoneal fluid obtained at laparoscopy from 49 women was measured for its content of prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), 6-keto-prostaglandin F1 alpha (6-KF), and thromboxane B2 (TxB2) by specific radioimmunoassa…